1. Remodeled tumor immune microenvironment (TIME) parade via natural killer cells reprogramming in breast cancer
   Mona M. Elanany et al, 2023, Life Sciences CrossRef
2. Impact of doxorubicin-loaded ferritin nanocages (FerOX) vs. free doxorubicin on T lymphocytes: a translational clinical study on breast cancer patients undergoing neoadjuvant chemotherapy
   Marta Sevieri et al, 2024, Journal of Nanobiotechnology CrossRef
3. Decoding cell death signalling: Impact on the response of breast cancer cells to approved therapies
   Lama Lozon et al, 2024, Life Sciences CrossRef
4. Phosphorous Dendron Micelles as a Nanomedicine Platform for Cooperative Tumor Chemoimmunotherapy via Synergistic Modulation of Immune Cells
   Mengsi Zhan et al, 2023, Advanced Materials CrossRef
5. Advances in natural killer cell therapies for breast cancer
   Seyedeh Zahra Fotook Kiaei et al, 2023, Immunology & Cell Biology CrossRef
6. Genistein Sensitizes Human Cholangiocarcinoma Cell Lines to Be Susceptible to Natural Killer Cells
   Chutipa Chiawpanit et al, 2022, Biology CrossRef
7. Immunomodulatory Activity of the Tyrosine Kinase Inhibitor Dasatinib to Elicit NK Cytotoxicity against Cancer, HIV Infection and Aging
   Andrea Rodríguez-Agustín et al, 2023, Pharmaceutics CrossRef
8. Tumor Organoid and Spheroid Models for Cervical Cancer
   Ivana Kutle et al, 2023, Cancers CrossRef